Gilead Sciences Inc. (GILD)

Gilead Sciences Inc., adjusted current assets

US$ in millions

		Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014
	As Reported
	Current assets
	Adjustments
	Add: Allowances for doubtful accounts, cash discounts and chargebacks
	Less: Deferred tax assets1
	After Adjustment
	Adjusted current assets

Based on: 10-K (filing date: 2019-02-26), 10-K (filing date: 2018-02-27), 10-K (filing date: 2017-02-27), 10-K (filing date: 2016-02-24), 10-K (filing date: 2015-02-25).

Gilead Sciences Inc., adjusted total assets

US$ in millions

		Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014
	As Reported
	Total assets
	Adjustments
	Add: Operating lease right-of-use asset (before adoption of FASB Topic 842)1
	Add: Allowances for doubtful accounts, cash discounts and chargebacks
	Less: Deferred tax assets2
	After Adjustment
	Adjusted total assets

Based on: 10-K (filing date: 2019-02-26), 10-K (filing date: 2018-02-27), 10-K (filing date: 2017-02-27), 10-K (filing date: 2016-02-24), 10-K (filing date: 2015-02-25).

Gilead Sciences Inc., adjusted total liabilities

US$ in millions

		Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014
	As Reported
	Total liabilities
	Adjustments
	Add: Operating lease liability (before adoption of FASB Topic 842)1
	After Adjustment
	Adjusted total liabilities

Based on: 10-K (filing date: 2019-02-26), 10-K (filing date: 2018-02-27), 10-K (filing date: 2017-02-27), 10-K (filing date: 2016-02-24), 10-K (filing date: 2015-02-25).

Gilead Sciences Inc., adjusted total Gilead stockholders’ equity

US$ in millions

		Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014
	As Reported
	Total Gilead stockholders’ equity
	Adjustments
	Less: Net deferred tax assets (liabilities)1
	Add: Allowances for doubtful accounts, cash discounts and chargebacks
	Add: Noncontrolling interest
	After Adjustment
	Adjusted total Gilead stockholders’ equity

Based on: 10-K (filing date: 2019-02-26), 10-K (filing date: 2018-02-27), 10-K (filing date: 2017-02-27), 10-K (filing date: 2016-02-24), 10-K (filing date: 2015-02-25).

Gilead Sciences Inc., adjusted capitalization table

US$ in millions

		Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014
	As Reported
	Current portion of long-term debt and other obligations, net
	Long-term debt, net, excluding current portion
	Total reported debt
	Total Gilead stockholders’ equity
	Total reported capital
	Adjustments to Debt
	Add: Operating lease liability (before adoption of FASB Topic 842)1
	Adjusted total debt
	Adjustments to Equity
	Less: Net deferred tax assets (liabilities)2
	Add: Allowances for doubtful accounts, cash discounts and chargebacks
	Add: Noncontrolling interest
	Adjusted total Gilead stockholders’ equity
	After Adjustment
	Adjusted total capital

Based on: 10-K (filing date: 2019-02-26), 10-K (filing date: 2018-02-27), 10-K (filing date: 2017-02-27), 10-K (filing date: 2016-02-24), 10-K (filing date: 2015-02-25).

Gilead Sciences Inc., adjusted net income attributable to Gilead

US$ in millions

	12 months ended	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014
	As Reported
	Net income attributable to Gilead
	Adjustments
	Add: Deferred income tax expense (benefit)1
	Add: Increase (decrease) in allowances for doubtful accounts, cash discounts and chargebacks
	Add: Other comprehensive income (loss)
	Add: Comprehensive income (loss), net of tax, attributable to noncontrolling interest
	After Adjustment
	Adjusted net income attributable to Gilead

Based on: 10-K (filing date: 2019-02-26), 10-K (filing date: 2018-02-27), 10-K (filing date: 2017-02-27), 10-K (filing date: 2016-02-24), 10-K (filing date: 2015-02-25).